SecBot SecBot
8-K ·Filed Nov 5, 2026

CI

Cigna Group
BULLISH
Impact 6/10
Horizonweeks Processed11d 15h ago SEC0001140361-26-042030
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The raised guidance and strong Cigna Healthcare margins support the bullish thesis, but the persistent weakness in Pharmacy Benefit Services (down 22% YoY) and the planned exit from Individual and Family Plans (IFP) medical business warrant monitoring. The Investor Day long-term targets (10-14% EPS CAGR, $50B cumulative OCF) provide a strategic framework; execution on the Accelerate to One productivity initiative will be key to sustaining margins.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+5
Entry
$301.48
T+0 close · Nov 5, 2026 · via day close
Latest settled
−1.73%
T+5 · $296.27
Vs SPY
−5.02%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $301.48entry
  2. T+1 · 11d ago −2.62%α −2.93% · $293.59
  3. T+5 · 5d ago −1.73%α −5.02% · $296.27
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Cigna reported Q3 2026 adjusted EPS of $7.98, above the $7.51 consensus, and total revenue of $73.7B, above the $72.45B consensus. The company raised its full-year 2026 adjusted EPS outlook to at least $30.60, up from at least $30.35, driven by strong Cigna Healthcare results and disciplined execution.

Key Financial Metrics

EPS (Adj.)
$7.98
est $7.51 · +6.3% · GAAP: $5.47
Revenue
$73.7B
est $72.5B · +1.7% · +5.6% YoY
Rating
beat

Key Facts

  • Q3 2026 total revenue $73.7B, +6% YoY, above $72.45B consensus
  • Q3 2026 adjusted EPS $7.98, above $7.51 consensus estimate
  • Full-year 2026 adjusted EPS outlook raised to at least $30.60 from at least $30.35
  • Cigna Healthcare segment adjusted income from operations pre-tax up 15% YoY to $1.193B
  • Evernorth Health Services adjusted revenue +6% YoY to $63.8B, but segment operating income -4% YoY
  • Pharmacy Benefit Services adjusted operating income down 22% YoY due to large client contract renewals
  • Year-to-date through Nov 4 repurchased 1.8M shares for ~$500M
  • Company hosted 2026 Investor Day, introduced 10%-14% adjusted EPS CAGR target and ~$50B cumulative operating cash flow through 2030

Financial Impact

Q3 adjusted EPS $7.98 vs consensus $7.51 (+6.3% beat); revenue $73.7B vs $72.45B (+1.7% beat); FY2026 guidance raised by $0.15 to at least $30.60

revenueepsguidance

Segment Breakdown

SegmentRevenueGrowth
Evernorth Health Services$63.8B+5.6%
Cigna Healthcare$11.7B+8.9%

Risk Factors

  • Pharmacy Benefit Services margin compression from large client renewals and strategic investments
  • Planned exit from Individual and Family Plans medical business as of Jan 1, 2027 creates uncertainty
  • Total customer relationships down 6% from Dec 2025 due to pharmacy and behavioral customer losses
  • Behavioral care customers down 19% from Dec 2025 due to termination of a government contract

Market Snapshot

Exchange
NYSE
Sector
Hospital & Medical Service Plans
Analyst Consensus
74% bullish (34 analysts)

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001140361-26-042030
Document: ef20084818_8k.htm0001140361-26-042030
Document: 0001140361-26-042030-index-headers.html0001140361-26-042030
Document: 0001140361-26-042030-index.html0001140361-26-042030
Document: 0001140361-26-042030.txt0001140361-26-042030
8-K Data (Synthetic)0001140361-26-042030

Track record

16 reports on CI

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 5, 202611d ago 8-K Bullish 6/10 Viewing Entry $301.48 to $296.27 Now $297.00 −1.49% ▼ −1.73% −5.02% vs SPY
  2. Oct 28, 202619d ago Press Release Neutral 2/10 Entry $298.41 to $301.48 Now $297.00 −0.47% ▲ +1.03% +5.75% vs SPY
  3. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $295.00 to $305.41 Now $297.00 +0.68% ▲ +3.53% +4.24% vs SPY
  4. Oct 20, 202627d ago Institutional Cluster Neutral 3/10 Entry $304.37 to $298.28 Now $297.00 −2.42% ▼ −2.00% −1.56% vs SPY
  5. Oct 9, 20265w ago 8-K Neutral 2/10 Entry $283.34 to $298.50 Now $297.00 +4.82% ▲ +5.35% +6.84% vs SPY
  6. Sep 30, 20266w ago 8-K Neutral 4/10 Entry $271.83 to $278.51 Now $297.00 +9.26% ▲ +2.46% +0.54% vs SPY
  7. Sep 3, 202610w ago 144 Neutral 2/10 Entry $286.26 to $280.76 Now $297.00 +3.75% ▼ −1.92% −0.77% vs SPY
  8. Aug 18, 202612w ago 144 Neutral 2/10 Entry $278.50 to $279.32 Now $297.00 +6.64% ▲ +0.29% +0.50% vs SPY
  9. Aug 4, 202614w ago 144 Neutral 2/10 Entry $273.45 to $273.87 Now $297.00 +8.61% ▲ +0.16% +0.25% vs SPY
  10. Jul 9, 202618w ago 3 Neutral 2/10 Entry $293.46 to $283.82 Now $297.00 +1.21% ▼ −3.28% −2.72% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens Wed (12h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026